Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, Mediated
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Mineralocorticoid receptors, both when in tissue extracts and when recombinant-derived, have equal affinity for the physiological mineralocorticoid aldosterone and for the glucocorticoids cortisol and corticosterone, which circulate at much higher concentrations than aldosterone. Such receptors are found in physiological mineralocorticoid target tissues (kidney, parotid, and colon) and in nontarget tissues such as hippocampus and heart. In mineralocorticoid target tissues the receptors are selective for aldosterone in vivo because of the presence of the enzyme 11 β-hydroxy-steroid dehydrogenase, which converts cortisol and corticosterone, but not aldosterone, to their 11-keto analogs. These analogs cannot bind to mineralocorticoid receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mineralocorticoid-responsive tissues such as the kidney, cortisol is enzymatically converted to cortisone, a metabolically inactive steroid (569).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, the type 2 enzyme inactivates the mineralocorticoid activity of cortisol in the kidney tubule (569), and inactivating mutations in the type 2 enzyme cause a syndrome of apparent mineralocorticoid excess (AME) (588).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, 11HSD2 prevents cortisol from overwhelming renal mineralocorticoid receptors (569), and in the placenta and other fetal tissues 11HSD2 (583, 584) also inactivates cortisol.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“The kidney has high levels of HSD11B2 activity which protects the mineralocorticoid receptor from activation by cortisol by inactivating it to cortisone (Edwards and Stewart, 1991, Funder et al., 1988).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Funder et al., 1988
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Krozowski, Z. S., & Funder, J. W. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6056 · Cited by 523
Self-citationThe Roles of Plasma Binding and Receptor Specificity in the Mineralocorticoid Action of Aldosterone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-994 · Cited by 232
Self-citationCharacterization of Rat Brain Aldosterone Receptors Reveals High Affinity for Corticosterone
BEAUMONT, K., & FANESTIL, D. D. (1983) · Endocrinology · doi:10.1210/endo-113-6-2043 · Cited by 193
Pearson Murphy, B. E. (1981) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(81)90226-0 · Cited by 178
Glucocorticoid Receptors in Rat Kidney: The Rinding of Tritiated-Dexamethasone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-1005 · Cited by 173
Self-citationAFFINITY OF LIQUORICE DERIVATIVES FOR MINERALOCORTICOID AND GLUCOCORTICOID RECEPTORS
ARMANINI, D., KARBOWIAK, I., & FUNDER, J. W. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb00038.x · Cited by 157
Self-citationGlucocorticoid and mineralocorticoid receptors for aldosterone
Rousseau, G. G., Baxter, J. D., Funder, J. W., Edelman, I. S., & Tomkins, G. M. (1972) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(72)90053-2 · Cited by 151
Self-citation
Research works printed but not linked: 4
- Krozowski, Z. S., Proceedings of the National Academy of Sciences of the United States of America 80: 6056 (1983).
- SHEPPARD, K, MINERALOCORTICOID SPECIFICITY OF RENAL TYPE-I RECEPTORS - INVIVO BINDING-STUDIES, AMERICAN JOURNAL OF PHYSIOLOGY 252: E224 (1987).
- SHEPPARD, K, TYPE-I RECEPTORS IN PAROTID, COLON, AND PITUITARY ARE ALDOSTERONE SELECTIVE INVIVO, AMERICAN JOURNAL OF PHYSIOLOGY 253: E467 (1987).
- STEWART, P.M., CORTICOSTEROIDS PEPT 39: 163 (1987).
Cited by
Items 501–600 of 1,001
Ontogeny and sexual dimorphic expression of mouse type 2 11β-hydroxysteroid dehydrogenase
Condon, J. C., Ricketts, M., Whorwood, C. B., & Stewart, P. M. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)04000-8 · Cited by 60
Ecto‐enzymes of lymphoid cells
Goding, J. W., & Howard, M. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01567.x · Cited by 60
Tagawa, M., Hagiwara, H., Takemura, A., Hirose, S., & Hirano, T. (1997) · General and Comparative Endocrinology · doi:10.1006/gcen.1997.6955 · Cited by 60
Shibata, N., Hayakawa, T., Takada, K., Hoshino, N., Minouchi, T., & Yamaji, A. (1998) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(97)00557-4 · Cited by 60
Nongenomic effects of aldosterone: cellular aspects and clinical implications
Lösel, R., Feuring, M., Falkenstein, E., & Wehling, M. (2002) · Steroids · doi:10.1016/s0039-128x(01)00176-3 · Cited by 60
Potential Regulation of Inflammation in the Lung by Local Metabolism of Hydrocortisone
Schleimer, R. P. (1991) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/4.2.166 · Cited by 60
Quinkler, M., Johanssen, S., Großmann, C., Bähr, V., Müller, M., Oelkers, W., & Diederich, S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6163 · Cited by 57
Brain mineralocorticoid receptor function in control of salt balance and stress-adaptation
de Kloet, E. R., & Joëls, M. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.12.045 · Cited by 59
Yang, J., Chang, C.-Y., Safi, R., Morgan, J., McDonnell, D. P., Fuller, P. J., Clyne, C. D., & Young, M. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0193 · Cited by 53
Shelat, S. G., King, J. L., Flanagan‐Cato, L. M., & Fluharty, S. J. (1999) · Neuroendocrinology · doi:10.1159/000054436 · Cited by 59
“likely results from the failure of corticosterone to reverse urinary sodium loss, due to its selective inactivation by 11β-hydroxysteroid dehydrogenase in the kidney [”
BackgroundFrindt, G., & Palmer, L. G. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00480.2011 · Cited by 59
6.3 Co-localization of brain corticosteroid receptors in the rat hippocampus
Eekelen, J. A. M. V., & de Kloet, E. R. (1992) · Progress in Histochemistry and Cytochemistry · doi:10.1016/s0079-6336(11)80102-6 · Cited by 59
Jamieson, P. M., Fuchs, E., Flugge, G., & Seckl, J. R. (1997) · Stress · doi:10.3109/10253899709014743 · Cited by 52
Nongenomic aldosterone effects: The cell membrane as a specific target of mineralocorticoid action
Wehling, M. (1995) · Steroids · doi:10.1016/0039-128x(94)00027-a · Cited by 58
Suzuki, T., Sasano, H., Suzuki, S., Hirasawa, G., Takeyama, J., Muramatsu, Y., Date, F., Nagura, H., & Krozowski, Z. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5227 · Cited by 53
“11bHSD2 is thought to confer mineralocorticoid specificity by preempting nonselective binding of cortisol to MR (9, 10 ) and to modulate access of glucocorticoids to the GR. Hirasawa et al. (11) recently demonstrated that 11bHSD2 colocalized with MR in sodium-transporting epithelia in adult human tissues.”
BackgroundHatakeyama, H., Inaba, S., & Miyamori, I. (1999) · Hypertension · doi:10.1161/01.hyp.33.5.1179 · Cited by 58
New Insights into Glucocorticoid and Mineralocorticoid Signaling: Lessons from Gene Targeting
Reichardt, H. M., Tronche, F., Berger, S. M., Kellendonk, C., & Schütz, G. (1999) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60108-8 · Cited by 59
Anomalies in the Endocrine Axes of the Guinea Pig: Relevance to Human Physiology and Disease*
Keightley, M.-C., & Fuller, P. J. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-1-30 · Cited by 59
Cooper, W. C., Jin, Y., & Penning, T. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703414200 · Cited by 58
Rafiq, K., Nakano, D., Ihara, G., Hitomi, H., Fujisawa, Y., Ohashi, N., Kobori, H., Nagai, Y., Kiyomoto, H., Kohno, M., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834103a9 · Cited by 58
Inhibition of human and rat 11β-hydroxysteroid dehydrogenases activities by bisphenol A
Guo, J., Yuan, X., Qiu, L., Zhu, W., Wang, C., Hu, G., Chu, Y., Ye, L., Xu, Y., & Ge, R. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.10.002 · Cited by 58
Psychobiology of depression/distress in congestive heart failure
York, K. M., Hassan, M., & Sheps, D. S. (2008) · Heart Failure Reviews · doi:10.1007/s10741-008-9091-0 · Cited by 58
Nakagawa, H., Oberwinkler, H., Nikolaev, V. O., Gaßner, B., Umbenhauer, S., Wagner, H., Saito, Y., Baba, H. A., Frantz, S., & Kühn, M. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000885 · Cited by 58
“The selectivity for aldosterone is achieved by the coexpression of 11β-hydroxysteroid dehydrogenase which inactivates glucocorticoids.(20) The activity of this enzyme is low in cardiomyocytes, and moreover, circulating concentrations of glucocorticoids are much higher than those of aldosterone.”
BackgroundAldosterone target organ protection by eplerenone
Rudolph, A. E., Rocha, R., & McMahon, E. G. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.047 · Cited by 58
Central Action of Adrenal Steroids During Stress and Adaptation
Reul, J. M. H. M., Sutanto, W., van Eekelen, J. A. M., Rothuizen, J. J., & de Kloet, E. R. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5799-5_15 · Cited by 58
Ploeger, B. A., Meulenbelt, J., & DeJongh, J. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8843 · Cited by 58
Mustonen, M., POUTANEN, M. H., Kellokumpu, S., de Launoit, Y., ISOMAA, V. V., Vihko, R., & Vihko, P. (1998) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0200067 · Cited by 58
“…type 2 enzyme possesses a predominant oxidative activity inactivating cortisol (11â-hydroxy) to cortisone (11-keto), and the activity of the enzyme has been shown to be crucial for aldosterone action in mineralocorticoid target tissues (Edwards et al. 1988, Funder et al. 1988, Mune et al. 1995).”
BackgroundDifferential promoter usage by the rat 11 beta-hydroxysteroid dehydrogenase gene
Moisan, M. P. (1992) · Molecular Endocrinology · doi:10.1210/me.6.7.1082 · Cited by 51
Regulation and dysregulation of epithelial Na+ channels
Palmer, L. G., Patel, A. B., & Frindt, G. (2011) · Clinical and Experimental Nephrology · doi:10.1007/s10157-011-0496-z · Cited by 57
“corticoid-remediated aldosteronism, in which circulating mineralocorticoid levels are elevated [11, 18], b-steroid dehydrogenase deficiency, in which high local levels of glucocorticoids mimic aldosterone effects [19], and Liddle’s syndrome, which involves a gain-of-function mutation of the Na channels themselves [20].”
BackgroundSwarbrick, M. M., Zhou, H., & Seibel, M. J. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0553 · Cited by 57
Role of renin–angiotensin–aldosterone system in adipose tissue dysfunction
Jing, F., Mogi, M., & Horiuchi, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.03.005 · Cited by 57
Inhibition of 11β-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis
Ackermann, D., Vogt, B., Escher, G., Dick, B., Reichen, J., Frey, B. M., & Frey, F. J. (1999) · Hepatology · doi:10.1002/hep.510300303 · Cited by 51
Identification of the molecular switch that regulates access of 5α-DHT to the androgen receptor
Penning, T. M., Bauman, D. R., Jin, Y., & Rižner, T. L. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.007 · Cited by 57
Takeda, M., Tatsumi, T., Matsunaga, S., Hayashi, H., Kimata, M., Honsho, S., Nishikawa, S., Mano, A., Shiraishi, J., Yamada, H., et al. (2007) · Hypertension Research · doi:10.1291/hypres.30.427 · Cited by 57
Carvajal, C. A., González, A. A., Romero, D. G., González, Á., Mosso, L. M., Lagos, E., Hevia, M. D. P., Rosati, M. P., Pérez‐Acle, T., Gómez-Sánchez, C. E., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021909 · Cited by 58
Glucocorticoid-Related Signaling Effects in Vascular Smooth Muscle Cells
Molnár, G. A., Lindschau, C., Dubrovska, G., Mertens, P. R., Kirsch, T., Quinkler, M. O., Gollasch, M., Wresche, S., Luft, F. C., Müller, D. N., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.105718 · Cited by 57
Selective activation of the probasin androgen-responsive region by steroid hormones
Kasper, S., Rennie, P., Bruchovsky, N., Lin, L., Cheng, H., Snoek, R., Dahlman-Wright, K., Gustafsson, J., Shiu, R., Sheppard, P., et al. (1999) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0220313 · Cited by 49
“Three proposed mechanisms to explain steroid specificity in a given tissue rely upon: (a) the absolute level of the steroid receptors to stimulate (Strahle et al. 1989) or repress (Konig et al. 1992) gene expression, (b) the metabolism of selective ligands within the target cell (Edwards et al. 1988, Funder et al. 198…”
BackgroundFarese, S., Kruse, A. E., Pasch, A., Dick, B., Frey, B. M., Uehlinger, D. E., & Frey, F. J. (2009) · Kidney International · doi:10.1038/ki.2009.269 · Cited by 56
Primary aldosteronism and salt
Funder, J. W. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1658-0 · Cited by 56
Self-citationRegulation of 11β-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol
Gomez-Sanchez, E. P., Ganjam, V., Chen, Y. J., Liu, Y., Zhou, M. Y., Toroslu, C., Romero, D. G., Hughson, M. D., de Rodriguez, A., & Gomez-Sanchez, C. E. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00409.2002 · Cited by 54
“Aldosterone binds the MR and modulates vectorial transport of sodium and water across epithelia in mineralocorticoid target tissues, such as the kidney and colon, where extrinsic specificity of the MR for aldosterone is provided by the enzyme 11 -hydroxysteroid dehydrogenase (11 HSD) type 2 (7, 8).”
BackgroundSakai, R. R., Lakshmi, V. M., Monder, C., & McEwen, B. S. (1992) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1992.tb00351.x · Cited by 56
Isoforms of 11β-hydroxysteroid dehydrogenase in human granulosa-lutein cells
Michael, A. E., Evagelatou, M., Norgate, D. P., Clarke, R. J., Antoniw, J. W., Stedman, B., Brennan, A., Welsby, R., Bujalska, I. J., Stewart, P. M., et al. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00118-4 · Cited by 56
Quinkler, M., Oelkers, W., & Diederich, S. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440087 · Cited by 49
11β‐Hydroxysteroid dehydrogenase and enzyme‐mediated receptor protection: Life after liquorice?
Walker, B. R., & Edwards, C. R. W. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03537.x · Cited by 55
Unusual evolution of 11β‐ and 17β‐hydroxysteroid and retinol dehydrogenases
Baker, M. E. (1996) · BioEssays · doi:10.1002/bies.950180112 · Cited by 50
The multifaceted mineralocorticoid receptor
Gomez‐Sanchez, E., & Gomez‐Sanchez, C. E. (2014) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2014.tb00569.x · Cited by 55
“apparent mineralocorticoid excess (AME) provided a clinical model to discover the role of 11β-HSD2 in aldosterone selectivity for MR (110, 139).”
Acclimation of Zebrafish to Transport Stress
Dhanasiri, A. K. S., Fernandes, J. M. O., & Kiron, V. (2013) · Zebrafish · doi:10.1089/zeb.2012.0843 · Cited by 55
“92,93 Therefore, further studies are needed to ascertain the possible involvement of increased mr and hsd11b2 transcripts in regulating stress during transport.”
Fortnightly review: tinnitus—investigation and management
Vesterager, V. (1997) · BMJ · doi:10.1136/bmj.314.7082.728 · Cited by 55
Inhibition of mineralocorticoid activity by the β-isoform of the human glucocorticoid receptor
Bamberger, C. M., Bamberger, A., Wald, M., Chrousos, G. P., & Schulte, H. M. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00167-7 · Cited by 55
Schulz‐Baldes, A., Berger, S., Grahammer, F., Warth, R., Goldschmidt, I., Peters, J., Schütz, G., Greger, R. F., & Bleich, M. (2001) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240100694 · Cited by 55
“Glucocorticoids are selectively inactivated by 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) in aldosterone-sensitive tissues [ 16 ], and the physiological aldosterone concentration is too low to activate GR so that mineralocorticoid action becomes specific.”
BackgroundKrozowski, Z. S., Obeyesekere, V. R., Smith, R. E., & Mercer, W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45918-2 · Cited by 55
Self-citationCorticosteroids, 11β‐Hydroxysteroid Dehydrogenase Isozymes and the Rabbit Choroid Plexus
Sinclair, A. J., Onyimba, C., Khosla, P., Vijapurapu, N., Tomlinson, J., Burdon, M., Stewart, P., Murray, P. I., Walker, E. A., & Rauz, S. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01569.x · Cited by 54
Albalat, R., Brunet, F., Laudet, V., & Schubert, M. (2011) · Genome Biology and Evolution · doi:10.1093/gbe/evr084 · Cited by 54
“This prereceptor regulation was first documented for mineralocorticoid receptors and Hsd11b enzymes (Funder et al. 1988; Oppermann et al. 1997).”
BackgroundVelázquez, H., Náray‐Fejes‐Tóth, A., Silva, T., Andújar, E., Reilly, R. F., Désir, G. V., & Ellison, D. H. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00036.x · Cited by 54
Glycyrrhetinic Acid Decreases Plasma Potassium Concentrations in Patients with Anuria
Serra, A. L., Uehlinger, D. E., Ferrari, P., Dick, B., Frey, B. M., Frey, F. J., & Vogt, B. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131191 · Cited by 54
When is cortisol a mineralocorticoid?
Clore, J. N., Schoolwerth, A. C., & Watlington, C. O. (1992) · Kidney International · doi:10.1038/ki.1992.421 · Cited by 54
Swords, F. M., Carroll, P. V., Kisalu, J., Wood, P. J., Taylor, N. F., & Monson, J. P. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01894.x · Cited by 52
11 -Hydroxysteroid Dehydrogenase Type II and Mineralocorticoid Receptor in Human Placenta
Hirasawa, G., Takeyama, J., Sasano, H., Fukushima, K., Suzuki, T., Muramatu, Y., Darnel, A. D., Kaneko, C., Hiwatashi, N., Toyota, T., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6429 · Cited by 51
“T IS NOW well established that 11b-hydroxysteroid dehydrogenase type II (11b-HSD2) confers specificity on the nonselective mineralocorticoid receptor (MR) (1) by converting biologically active glucocorticoids to inactive metabolites, thereby allowing the approximately 1000-fold lower circulating levels of aldosterone…”
BackgroundVázquez, D. M., López, J. F., Morano, M. I., Kwak, S. P., Watson, S. J., & Akil, H. (1998) · Endocrinology · doi:10.1210/endo.139.7.6095 · Cited by 49
The purification of 11β-hydroxysteroid dehydrogenase from mouse liver microsomes
Maser, E., & Bannenberg, G. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90153-8 · Cited by 54
Basson, J., Simino, J. M., & Rao, D. C. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0241-8 · Cited by 53
“Apparent mineralocorticoid excess Steroid/aldosterone synthesis 11β-hydroxysteroid dehydrogenase (11B-HSD) Impaired conversion of cortisol to cortisone results in cortisol-mediated hyperactivation of MR [115, 116]”
BackgroundBROWN, R. W., CHAPMAN, K. E., MURAD, P., EDWARDS, C. R. W., & SECKL, J. R. (1996) · Biochemical Journal · doi:10.1042/bj3130997 · Cited by 52
Corticosteroids, Stress, and Aginga
de Kloet, E. R. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb38679.x · Cited by 53
Dysregulation of 11beta-hydroxysteroid dehydrogenases: implications during pregnancy and beyond
Konstantakou, P., Mastorakos, G. P., Vrachnis, N., Tomlinson, J., & Valsamakis, G. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2016.1171308 · Cited by 53
“Importantly, circulating glucocorticoids are modulated not only systemically by the hypothalamic-pituitary-adrenal axis (HPA), but also locally in target-tissues with a ‘‘pre-receptor’’ mechanism involving the 11beta-hydroxysteroid dehydrogenase (11beta-HSD) enzymic system [11,12].”
BackgroundCortisol to cortisone: Glucocorticoid to mineralocorticoid
Stewart, P. M., & Mason, J. I. (1995) · Steroids · doi:10.1016/0039-128x(94)00024-7 · Cited by 51
Nontraditional aspects of aldosterone physiology
Ngarmukos, C., & Grekin, R. J. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1122 · Cited by 52
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Odermatt, A., & Nashev, L. G. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.01.007 · Cited by 51
Adrenocortical Responses to Stress and Their Modulation in Free‐Living Vertebrates
Wingfield, J. C., & Romero, L. M. (2000) · Comprehensive physiology · doi:10.1002/j.2040-4603.2000.tb01516.x · Cited by 51
High affinity aldosterone binding sites (Type I receptors) in the mammalian inner ear
Pitovski, D. Z., Drescher, M. J., & Drescher, D. G. (1993) · Hearing Research · doi:10.1016/0378-5955(93)90088-i · Cited by 51
Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart
Wilson, P., Morgan, J., Funder, J. W., Fuller, P. J., & Young, M. J. (2009) · Clinical Science · doi:10.1042/cs20080247 · Cited by 44
Self-citationGenetic Diseases of Steroid Metabolism
(1994) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)61147-4 · Cited by 43
The functional roles of 11β-HSD1: vascular tissue, testis and brain
Morris, D. J., Brem, A. S., Ge, R., Jellinck, P. H., Sakai, R. R., & Hardy, M. P. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00094-7 · Cited by 51
Mineralocorticoid receptor antagonists do not block rapid ERK activation by aldosterone
Rossol-Haseroth, K., Zhou, Q., Braun, S., Boldyreff, B., Falkenstein, E., Wehling, M., & Lösel, R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.026 · Cited by 51
The 11β hydroxysteroid dehydrogenase 2 exists as an inactive dimer
Gómez-Sánchez, E. P., Ganjam, V. K., Chen, Y. J., Liu, Y., Clark, S. A., & Gómez-Sánchez, C. E. (2001) · Steroids · doi:10.1016/s0039-128x(01)00119-2 · Cited by 51
Li, K. X. Z., Smith, R. E., Ferrari, P., Funder, J. W., & Krozowski, Z. S. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(96)03822-1 · Cited by 51
Self-citationBaker, M. E. (1994) · Steroids · doi:10.1016/0039-128x(94)90109-0 · Cited by 51
Penning, T. M. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.01.009 · Cited by 50
Disorders of Potassium Balance
Mount, D. B., & Zandi‐Nejad, K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10017-x · Cited by 50
Mineralocorticoid receptors: Emerging complexity and functional diversity
Odermatt, A., & Atanasov, A. G. (2008) · Steroids · doi:10.1016/j.steroids.2008.10.010 · Cited by 50
Mineralocorticoid receptor activation and cardiac fibrosis
Young, M. J., Lam, E. Y. M., & Rickard, A. J. (2007) · Clinical Science · doi:10.1042/cs20060275 · Cited by 50
Sampath-Kumar, R., Matthews, S. G., & Yang, K. (1998) · Biology of Reproduction · doi:10.1095/biolreprod59.6.1378 · Cited by 42
Genetic manipulation of 11β-hydroxysteroid dehydrogenases in mice
Paterson, J. M., Seckl, J. R., & Mullins, J. J. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00017.2005 · Cited by 50
“(type 1 corticosteroid) receptors (19, 21).”
Corticosteroid-regulated genes in rat kidney: mining time series array data
Almon, R. R., Lai, W., DuBois, D. C., & Jusko, W. J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00196.2005 · Cited by 50
“Corticosteroids are capable of binding to both the glucocorticoid and the mineralocorticoid receptors in the kidney (15, 19).”
White, P. C., Mune, T., Rogerson, F. M., Kayes, K. M., & Agarwal, A. K. (1997) · Steroids · doi:10.1016/s0039-128x(96)00164-x · Cited by 50
Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit, S., Bernheim, J., & Podjarny, E. (2002) · PubMed · Cited by 50
Down-regulation of hepatic and renal 11β-hydroxysteroid dehydrogenase in rats with liver cirrhosis
Escher, G., Nawrocki, A. R., Staub, T., Vishwanath, B. S., Frey, B. M., Reichen, J., & Frey, F. J. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70645-6 · Cited by 50
Congenital and acquired syndromes of apparent mineralocorticoid excess
Edwards, C. R. W., Walker, B. R., Benediktsson, R., & Seckl, J. R. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90114-c · Cited by 50
Regulation of sodium transport in M-1 cells
Nakhoul, N. L., Hering-Smith, K. S., Gambala, C. T., & Hamm, L. L. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.275.6.f998 · Cited by 50
“Glucocorticoids are potent ligands for mineralocorticoid receptors, but mineralocorticoid target tissues are usually ‘‘protected’’ by metabolism of endogenous glucocorticoids by 11-b-hydroxysteroid dehydrogenase (20).”
BackgroundAldosterone: Renal Action and Physiological Effects
Johnston, J. G., Welch, A., Cain, B. D., Sayeski, P. P., Gumz, M. L., & Wingo, C. S. (2023) · Comprehensive physiology · doi:10.1002/cphy.c190043 · Cited by 49
Revisiting Licorice as a functional food in the management of neurological disorders: Bench to trend
Sharma, R., Singla, R. K., Banerjee, S., & Sharma, R. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105452 · Cited by 49
Hsd11b2 Haploinsufficiency in Mice Causes Salt Sensitivity of Blood Pressure
Bailey, M. A., Craigie, E., Livingstone, D. E. W., Kotelevtsev, Y. V., Al-Dujaili, E. A. S., Kenyon, C. J., & Mullins, J. J. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.163782 · Cited by 47
Regulation of Corticosteroidogenic Genes by MicroRNAs
Robertson, S., Diver, L. A., Alvarez‐Madrazo, S., Livie, C., Ejaz, A., Fraser, R., Connell, J., MacKenzie, S. M., & Davies, E. (2017) · International Journal of Endocrinology · doi:10.1155/2017/2021903 · Cited by 49
“Putative miRNA binding sites were identified in the 3′UTR in eachof the seven human corticosteroidogenic genes (CYP11B1, CYP11B2, CYP11A1, CYP17A1, CYP21A2, HSD3B2, and StAR) and in the two metabolising genes (HSD11B1, HSD11B2) analysed (Table 2).”
InfluentialMaser, E., Friebertshäuser, J., & Völker, B. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00180-1 · Cited by 49
11β-Hydroxysteroid Dehydrogenase and Its Role in the Syndrome of Apparent Mineralocorticoid Excess
White, P. C., Mune, T., Rogerson, F. M., Kayes, K. M., & Agarwal, A. K. (1997) · Pediatric Research · doi:10.1203/00006450-199701000-00004 · Cited by 49
Aldosteronoma in a dog with polyuria as the leading symptom
Rijnberk, A., Kooistra, H. S., van Vonderen, I. K., Mol, J. A., Voorhout, G., van Sluijs, F. J., IJzer, J., van den Ingh, T. S. G. A. M., de Boer, P., & Boer, W. H. (2001) · Domestic Animal Endocrinology · doi:10.1016/s0739-7240(01)00090-x · Cited by 49
Genetics of arterial hypertension and hypotension
Rosskopf, D., Schürks, M., Rimmbach, C., & Schäfers, R. F. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0133-2 · Cited by 49
The importance of pharmacokinetic and receptor studies in drug safety evaluation
Eason, C., Bonner, F. W., & Parke, D. V. (1990) · Regulatory Toxicology and Pharmacology · doi:10.1016/0273-2300(90)90028-a · Cited by 49
Metabolism of Synthetic Corticosteroids by 11β-hydroxysteroid-Dehydrogenases in Man
Diederich, S., Hanke, B., Burkhardt, P., Müller, M., Schöneshöfer, M., Bähr, V., & Oelkers, W. (1998) · Steroids · doi:10.1016/s0039-128x(98)00039-7 · Cited by 49
Ploeger, B. A., Mensinga, T. T., Sips, A. J. A. M., Meulenbelt, J., & DeJongh, J. (2000) · Pharmaceutical Research · doi:10.1023/a:1007661209921 · Cited by 49
“In the causal chain of licorice-induced hypertension and electrolyte disturbances, the inhibition of the enzyme 11-b-HSD is directly associated with the (over)consumption of licorice, and long-term inhibition of this enzyme may finally lead to hypertension (2, 3 ).”
Metadata
- Authors
- Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I.
- Affiliations
- Medical Research Centre, Prince Henry's Hospital, Melbourne, Australia 3004.
- Venue
- Science
- Published
- 1988-10-28
- Volume
- 242
- Issue
- 4878
- Pages
- 583-585
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2148114970
- Semantic Scholar
- ae47dabb539e84fc85ea0bfd3f1a669037f37264
- Cited by
- 1,628
- References
- 19
- Citations by year
- 2026: 15 · 2025: 7 · 2024: 21 · 2023: 21 · 2022: 16 · 2021: 25 · 2020: 25 · 2019: 32 · 2018: 32 · 2017: 33 · 2016: 26 · 2015: 30 · 2014: 37 · 2013: 44 · 2012: 56
- FWCI
- 30.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- mineralocorticoid receptor, aldosterone, glucocorticoids, cortisol, corticosterone, 11β-hydroxysteroid dehydrogenase, 11-keto steroids, kidney, parotid gland, colon, hippocampus, heart
- MeSH terms
- Adrenalectomy, Aldosterone, Animals, Carbenoxolone, Colon, Corticosterone, Heart, Hippocampus, Hydrocortisone, Hydroxysteroid Dehydrogenases, Kidney, Parotid Gland, Receptors, Steroid, Receptors, Mineralocorticoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.